Currently used non-specific extracellular MR contrast media
- 1 December 2003
- journal article
- review article
- Published by Springer Nature in European Radiology
- Vol. 13 (12) , 2688-2698
- https://doi.org/10.1007/s00330-003-1912-x
Abstract
Magnetic resonance contrast agents have demonstrated their clinical usefulness in a variety of organs for improved detection of various neoplastic, inflammatory and functional abnormalities. Gadolinium chelates are the most widely used. They are extracellular, non-specific contrast agents. Their use in many clinical indications is justified because, in conjunction with improved imaging techniques, these safe and image-enhancing contrast agents add morphologic and functional information compared with unenhanced MR images. This article describes the commercially available compounds, and summarizes their approval status on the international market regarding indications and doses. Their mechanisms of action, biodistributions, toxicities and tolerance profiles in normal and high-risk patient populations are described. Additionally, this article reviews the specific recommendations by the manufacturers for patients at risk. Finally, their main clinical applications are reviewed.Keywords
This publication has 50 references indexed in Scilit:
- Value of 1.0-M gadolinium chelates: review of preclinical and clinical data on gadobutrolEuropean Radiology, 2002
- Three-dimensional Gadolinium-enhanced MR Angiography: Applications for Abdominal ImagingRadioGraphics, 2001
- Endometrial carcinoma: Assessment of myometrial invasion with plain and gadolinium-enhanced MR imagingJournal of Magnetic Resonance Imaging, 2000
- Non-invasive vascular imaging: assessing tumour vascularityEuropean Radiology, 1998
- Safety of ProHance in special populationsEuropean Radiology, 1997
- Worldwide clinical safety assessment of gadoteridol injection: an updateEuropean Radiology, 1997
- Quantitative analysis of gadopentetate dimeglumine excreted in breast milkJournal of Magnetic Resonance Imaging, 1993
- MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol.Radiology, 1991
- Excretion of gadopentetate dimeglumine in human breast milk.American Journal of Roentgenology, 1990
- The relationship between thermodynamics and the toxicity of gadolinium complexesMagnetic Resonance Imaging, 1990